UR-1827

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameUR-1827
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAcetylcholinesterase inhibitorsAdrenergic receptors antagonistsMonoamine oxidase A inhibitors
TargetsAcetylcholinesteraseMonoamine oxidase AAdrenergic receptors
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUbe Industries Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUbe Industries Ltd
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A